Paul Curtis Hendrie

Paul Curtis Hendrie is a Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and a practicing physician at Fred Hutch Cancer Center. He specializes in complex blood disorders, treating both malignant conditions like leukemia and lymphoma, and non-malignant diseases such as aplastic anemia, with emphasis on rare disorders requiring clinical trial participation.

Education:

• Undergraduate Degree: Indiana University Bloomington
• Medical Degree: Indiana University School of Medicine (1995)
• Residency: Internal Medicine, Indiana University School of Medicine
• Fellowship: Hematology, University of Washington

Dr. Hendrie's research spans hematologic malignancies and rare blood disorders, with particular expertise in Erdheim-Chester disease, myelodysplastic syndromes, and thrombosis in cancer patients. His clinical philosophy centers on diagnostic precision and patient-centered care planning, translating complex findings into understandable treatment pathways that may include novel therapies through clinical trials.

Publication analysis reveals consistent focus on acute myeloid leukemia therapeutics, risk stratification models, and consensus guidelines for rare histiocytic disorders. His work demonstrates evolution from molecular techniques (2005 gene therapy research) toward contemporary clinical trial design and national guideline development, particularly in venous thromboembolism management for cancer patients.

At Fred Hutch, Dr. Hendrie collaborates within a multidisciplinary team including patient care coordinators, specialized nurses, and support services (dietitians, social workers, psychiatrists) to provide comprehensive care for blood disorder patients. The center's research infrastructure enables his active participation in clinical trials that have contributed to FDA-approved treatments and global care standards.